Renal Cancer - Results from #1060

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma. March 3, 2023

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study. March 3, 2023

Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective-prospective cohort multicentre study. March 2, 2023

Initial experience of robot-assisted partial nephrectomy with Hugo™ RAS system: implications for surgical setting. March 2, 2023

Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study. March 1, 2023

Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits. March 1, 2023

A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma. February 28, 2023

Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept. February 28, 2023

The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis. February 27, 2023

Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018. February 27, 2023

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma. February 24, 2023

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO). February 24, 2023

Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database. February 23, 2023

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma. February 23, 2023

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma. February 22, 2023

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. February 22, 2023

The association of healthy lifestyle index score and the risk of renal cell cancer in the Netherlands cohort study. February 21, 2023

Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma. February 21, 2023

Mitochondrial metabolism in primary and metastatic human kidney cancers. February 21, 2023

Urine supernatant reveals a signature that predicts survival in clear cell renal cell carcinoma. February 20, 2023

Page 54 of 456